Chronic activation of the NF-κB/p65 pathway constitutes a central axis in obesity-associated inflammation, promoting the sustained release of proinflammatory cytokines and exacerbating metabolic stress at both systemic and tissue levels [25,39]. Here, NFKB1 is linked to obesity disorder.